幽門螺桿菌認(rèn)識(shí)到幽門螺桿菌在消化性潰瘍、胃腺癌和原發(fā)性胃淋巴瘤中的關(guān)鍵作用。新的幽門螺桿菌物種現(xiàn)在經(jīng)常被發(fā)現(xiàn)。通過(guò)將該雜志的范圍擴(kuò)大到整個(gè)螺旋桿菌研究領(lǐng)域，我們將加強(qiáng)胃腸學(xué)、微生物學(xué)、疫苗開(kāi)發(fā)和實(shí)驗(yàn)動(dòng)物科學(xué)等各個(gè)領(lǐng)域之間的交流。隨著新治療的分子生物學(xué)和臨床試驗(yàn)的新發(fā)現(xiàn)為患者護(hù)理和治療開(kāi)辟了廣泛的可能性，幽門螺桿菌將在那里報(bào)告結(jié)果。

Helicobacter recognises the critical role that has been established for Helicobacter pylori in peptic ulcer, gastric adenocarcinoma, and primary gastric lymphoma. New helicobacter species are now regularly being discovered. By broadening the scope of the Journal to the entire field of helicobacter research, we will increase communication among the various fields such as gastroenterology; microbiology; vaccine development and laboratory animal science. As new discoveries in molecular biology and clinical trials of new treatment open up a wide range of possibilities for patient care and cure, Helicobacter will be there to report the results.